• العربية
    • English
  • English 
    • العربية
    • English
  • Login
Home
Publisher PoliciesTerms of InterestHelp Videos
Submit Thesis
IntroductionIUGSpace Policies
JavaScript is disabled for your browser. Some features of this site may not work without it.
View Item 
  •   Home
  • Faculty of Science
  • PhD and MSc Theses- Faculty of Science
  • View Item
  •   Home
  • Faculty of Science
  • PhD and MSc Theses- Faculty of Science
  • View Item

Please use this identifier to cite or link to this item:

http://hdl.handle.net/20.500.12358/21985
TitleCYP2D6 genotyping of breast cancer patients under treatment with tamoxifen in Gaza Strip
Title in Arabicتحديد الطراز الجيني لبروتين CYP2D6 لمرضى سرطان الثدي الخاضعين للعلاج بعقار تاموكسيفين في قطاع غزة
Abstract

Introduction: Tamoxifen is the standard antihormonal therapy for breast cancer. It undergoes chemical digestion to more active compounds inside the liver microsome through the cytochrome P450 isoform CYP2D6, an enzyme encoded on CYP2D6 gene. CYP2D6 is polymorphic in which polymorphisms alter the enzyme activity by means of poor metabolism, intermediate metabolism, and ultra-rapid metabolism. Objectives: the study aimed to genotype palestinian breast cancer patients for common polymorphisms that lower or abolish CYP2D6 activity (CYP2D6*3, *4, *6, *9, *10, and *17), as well studying the effect of polymorphisms on the clinical outcome and establishing the role of pharmacogenetics in disease follow up. Methodology: Fifty eight whole blood samples were submitted to DNA extraction with affenity column technology, followed by long range PCR and a newly designed allele-specific PCR. Data were collected from medical records; in addition, patients were interviewed. All data were analyzed by SPSS software version 21. Results: two patients had the genotype *1/*3, three patients had the genotype *1/*4, one patient with the genotype *9/*9, one patient with the genotype *3/*10, and negative results for *17 allele. The allelic frequencies for *3, *4, *9, and *10 alleles were 2.59%, 2.59%, 4.3%, and 0.86%, respectively. The study showed a significant correlation between the appearance of alleles and the clinical outcomes. Conclusion: there was a significant allele frequency among the study population, and the presence of allelic variants led to a noteworthy effect on the clinical outcome of tamoxifen therapy; therefore, tamoxifen pharmacogenetic assessment plays a key role in treatment success. Key words: Breast cancer, Genotyping, CYP2D6, Polymorphism, Pharmacogenetics, Gaza strip.

Authors
Ayesh, Adham A
Supervisors
Abed, Abdalla Asaf
Typeرسالة ماجستير
Date2016
LanguageEnglish
Publisherالجامعة الإسلامية - غزة
Citation
License
Collections
  • PhD and MSc Theses- Faculty of Science [445]
Files in this item
file_1.pdf2.909Mb
Thumbnail

The institutional repository of the Islamic University of Gaza was established as part of the ROMOR project that has been co-funded with support from the European Commission under the ERASMUS + European programme. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.

Contact Us | Send Feedback
 

 

Browse

All of IUGSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsSupervisorsThis CollectionBy Issue DateAuthorsTitlesSubjectsSupervisors

My Account

LoginRegister

Statistics

View Usage Statistics

The institutional repository of the Islamic University of Gaza was established as part of the ROMOR project that has been co-funded with support from the European Commission under the ERASMUS + European programme. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.

Contact Us | Send Feedback